NO20034439L - Benzamidinderivater - Google Patents

Benzamidinderivater

Info

Publication number
NO20034439L
NO20034439L NO20034439A NO20034439A NO20034439L NO 20034439 L NO20034439 L NO 20034439L NO 20034439 A NO20034439 A NO 20034439A NO 20034439 A NO20034439 A NO 20034439A NO 20034439 L NO20034439 L NO 20034439L
Authority
NO
Norway
Prior art keywords
benzamidine derivatives
benzamidine
derivatives
Prior art date
Application number
NO20034439A
Other languages
English (en)
Other versions
NO20034439D0 (no
Inventor
Koichi Fujimoto
Naoki Tanaka
Ikuko Shimada
Fumitoshi Asai
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20034439D0 publication Critical patent/NO20034439D0/no
Publication of NO20034439L publication Critical patent/NO20034439L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034439A 2001-04-05 2003-10-03 Benzamidinderivater NO20034439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001107615 2001-04-05
PCT/JP2002/003355 WO2002081448A1 (fr) 2001-04-05 2002-04-03 Derive benzamidine

Publications (2)

Publication Number Publication Date
NO20034439D0 NO20034439D0 (no) 2003-10-03
NO20034439L true NO20034439L (no) 2003-12-02

Family

ID=18959909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034439A NO20034439L (no) 2001-04-05 2003-10-03 Benzamidinderivater

Country Status (19)

Country Link
US (1) US7030138B2 (no)
EP (1) EP1375482A4 (no)
KR (1) KR20030087056A (no)
CN (1) CN1610666A (no)
AU (1) AU2002246336B2 (no)
BR (1) BR0208678A (no)
CA (1) CA2442904A1 (no)
CO (1) CO5550436A2 (no)
CZ (1) CZ20032728A3 (no)
HU (1) HUP0400384A3 (no)
IL (1) IL158076A0 (no)
MX (1) MXPA03009097A (no)
NO (1) NO20034439L (no)
NZ (1) NZ528517A (no)
PL (1) PL363961A1 (no)
RU (1) RU2256652C1 (no)
SK (1) SK12082003A3 (no)
WO (1) WO2002081448A1 (no)
ZA (1) ZA200307646B (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10162114A1 (de) * 2001-12-12 2003-06-26 Schering Ag Neue Amidin-Derivate und deren Verwendung in Arzneimitteln
GB0321781D0 (en) 2003-09-17 2003-10-15 Toppan Printing Company Ltd Electroluminescent device
EP1682600B1 (en) 2003-11-10 2013-01-23 Cambridge Display Technology Limited Dibenzosilol polymers, their preparation and uses
GB0329364D0 (en) 2003-12-19 2004-01-21 Cambridge Display Tech Ltd Optical device
EP2650290A1 (en) * 2004-03-31 2013-10-16 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
KR100804452B1 (ko) 2004-03-31 2008-02-20 닛뽕소다 가부시키가이샤 환형 아민 화합물 및 유해 생물 방제제
GB0422391D0 (en) 2004-10-08 2004-11-10 Cambridge Display Tech Ltd Light emitting device
GB0427266D0 (en) 2004-12-13 2005-01-12 Cambridge Display Tech Ltd Phosphorescent OLED
JP4966203B2 (ja) 2004-12-24 2012-07-04 シーディーティー オックスフォード リミテッド 発光装置
GB0428444D0 (en) 2004-12-29 2005-02-02 Cambridge Display Tech Ltd Conductive polymer compositions in opto-electrical devices
GB0428445D0 (en) 2004-12-29 2005-02-02 Cambridge Display Tech Ltd Blue-shifted triarylamine polymer
GB2460358B (en) 2004-12-29 2010-01-13 Cambridge Display Tech Ltd Rigid amines
GB2426376B (en) * 2005-05-19 2008-12-03 Cdt Oxford Ltd Light-emitting device
GB0514476D0 (en) 2005-07-14 2005-08-17 Cambridge Display Tech Ltd Conductive polymer compositions in opto-electrical devices
EA014057B1 (ru) 2005-10-06 2010-08-30 Ниппон Сода Ко., Лтд. Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями
GB2433509A (en) 2005-12-22 2007-06-27 Cambridge Display Tech Ltd Arylamine polymer
GB0526185D0 (en) 2005-12-22 2006-02-01 Cambridge Display Tech Ltd Electronic device
GB0526393D0 (en) 2005-12-23 2006-02-08 Cdt Oxford Ltd Light emissive device
GB2433833A (en) 2005-12-28 2007-07-04 Cdt Oxford Ltd Micro-cavity OLED layer structure with transparent electrode
US7943646B2 (en) 2006-01-31 2011-05-17 Dong Wha Pharmaceutical Co., Ltd. Benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same
GB2434916A (en) * 2006-02-03 2007-08-08 Cdt Oxford Ltd OLED for full colour display
GB2434915A (en) 2006-02-03 2007-08-08 Cdt Oxford Ltd Phosphoescent OLED for full colour display
GB0605120D0 (en) 2006-03-14 2006-04-26 Novartis Ag Organic Compounds
GB2440934B (en) 2006-04-28 2009-12-16 Cdt Oxford Ltd Opto-electrical polymers and devices
EP2047541A2 (en) * 2006-08-01 2009-04-15 Cambridge Display Technology Limited Methods of manufacturing opto-electrical devices
GB0617167D0 (en) * 2006-08-31 2006-10-11 Cdt Oxford Ltd Compounds for use in opto-electrical devices
GB0617723D0 (en) * 2006-09-08 2006-10-18 Cambridge Display Tech Ltd Conductive polymer compositions in opto-electrical devices
GB2442724B (en) * 2006-10-10 2009-10-21 Cdt Oxford Ltd Light emissive device
GB0620045D0 (en) 2006-10-10 2006-11-22 Cdt Oxford Ltd Otpo-electrical devices and methods of making the same
US20100249402A1 (en) * 2007-07-27 2010-09-30 Dong Wha Pharmaceutical Co. Ltd. Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteporosis comprising the same
GB2454890B (en) 2007-11-21 2010-08-25 Limited Cambridge Display Technology Light-emitting device and materials therefor
GB2455747B (en) 2007-12-19 2011-02-09 Cambridge Display Tech Ltd Electronic devices and methods of making the same using solution processing techniques
GB2466730B (en) * 2008-01-23 2011-04-20 Cambridge Display Tech Ltd Phosphorescent compositions and their use in displays
GB2456788B (en) 2008-01-23 2011-03-09 Cambridge Display Tech Ltd White light emitting material
GB2458454B (en) 2008-03-14 2011-03-16 Cambridge Display Tech Ltd Electronic devices and methods of making the same using solution processing techniques
GB2459895B (en) 2008-05-09 2011-04-27 Cambridge Display Technology Limited Organic light emissive device
US20110177580A1 (en) * 2008-05-30 2011-07-21 Novo Nordisk Healthcare Ag Method of Controlling a Polypeptide Modification Reaction
GB2461527B (en) * 2008-07-01 2011-08-03 Limited Cambridge Display Technology Organic electronic device
GB2462410B (en) 2008-07-21 2011-04-27 Cambridge Display Tech Ltd Compositions and methods for manufacturing light-emissive devices
GB2462122B (en) 2008-07-25 2013-04-03 Cambridge Display Tech Ltd Electroluminescent materials
GB2462314B (en) * 2008-08-01 2011-03-16 Cambridge Display Tech Ltd Organic light-emiting materials and devices
GB0814161D0 (en) 2008-08-01 2008-09-10 Cambridge Display Tech Ltd Blue-light emitting material
GB0814971D0 (en) 2008-08-15 2008-09-24 Cambridge Display Tech Ltd Opto-electrical devices and methods of manufacturing the same
GB2462688B (en) 2008-08-22 2012-03-07 Cambridge Display Tech Ltd Opto-electrical devices and methods of manufacturing the same
GB2469497B (en) 2009-04-16 2012-04-11 Cambridge Display Tech Ltd Polymers comprising fluorene derivative repeat units and their preparation
GB2469500B (en) 2009-04-16 2012-06-06 Cambridge Display Tech Ltd Method of forming a polymer
GB0906554D0 (en) 2009-04-16 2009-05-20 Cambridge Display Tech Ltd Organic electroluminescent device
GB2469498B (en) 2009-04-16 2012-03-07 Cambridge Display Tech Ltd Polymer and polymerisation method
GB2475247B (en) 2009-11-10 2012-06-13 Cambridge Display Tech Ltd Organic optoelectronic device and method
GB2475246B (en) 2009-11-10 2012-02-29 Cambridge Display Tech Ltd Organic opto-electronic device and method
GB2487342B (en) 2010-05-14 2013-06-19 Cambridge Display Tech Ltd Host polymer comprising conjugated repeat units and non-conjugated repeat units for light-emitting compositions, and organic light-emitting devices
GB2484253B (en) 2010-05-14 2013-09-11 Cambridge Display Tech Ltd Organic light-emitting composition and device
GB2485001A (en) 2010-10-19 2012-05-02 Cambridge Display Tech Ltd OLEDs
WO2012104628A1 (en) 2011-01-31 2012-08-09 Cambridge Display Technology Limited Polymer
GB201122316D0 (en) 2011-12-23 2012-02-01 Cambridge Display Tech Ltd Polymer, polymer composition and organic light-emitting device
GB2494096B (en) 2011-01-31 2013-12-18 Cambridge Display Tech Ltd Polymer
GB201105582D0 (en) 2011-04-01 2011-05-18 Cambridge Display Tech Ltd Organic light-emitting device and method
GB201107905D0 (en) 2011-05-12 2011-06-22 Cambridge Display Tech Ltd Light-emitting material, composition and device
GB201110564D0 (en) 2011-06-22 2011-08-03 Cambridge Display Tech Ltd Polymer and optoelectronic device
KR101986859B1 (ko) 2011-07-04 2019-06-07 캠브리지 디스플레이 테크놀로지 리미티드 중합체, 단량체 및 중합체의 형성 방법
GB201111742D0 (en) 2011-07-08 2011-08-24 Cambridge Display Tech Ltd Solution
GB201210131D0 (en) 2011-11-02 2012-07-25 Cambridge Display Tech Ltd Light emitting composition and device
GB201118997D0 (en) 2011-11-03 2011-12-14 Cambridge Display Tech Ltd Electronic device and method
GB201200619D0 (en) 2012-01-16 2012-02-29 Cambridge Display Tech Ltd Polymer
GB2515909B (en) 2012-01-31 2020-07-15 Cambridge Display Tech Ltd Composition comprising a fluorescent light-emitting material and triplet-accepting polymer and use thereof
GB2508410A (en) 2012-11-30 2014-06-04 Cambridge Display Tech Ltd Polymer and organic electronic device
GB2514818B (en) 2013-06-05 2015-12-16 Cambridge Display Tech Ltd Polymer and organic electronic device
US12092597B2 (en) * 2021-12-03 2024-09-17 Palo Alto Research Center Incorporated Arylphosphine nanomaterial constructs for moisture-insensitive formaldehyde gas sensing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2004A (en) * 1841-03-12 Improvement in the manner of constructing and propelling steam-vessels
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
ATE233240T1 (de) 1994-12-02 2003-03-15 Yamanouchi Pharma Co Ltd Neues amidinonaphthylderivat oder dessen salz
TW542822B (en) 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
AU3857300A (en) 1999-02-11 2000-08-29 Cor Therapeutics, Inc. Inhibitors of factor xa
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
RU2222529C2 (ru) 1999-10-28 2004-01-27 Санкио Компани, Лимитед Производные бензамидина

Also Published As

Publication number Publication date
SK12082003A3 (sk) 2004-09-08
US20040147555A1 (en) 2004-07-29
HUP0400384A2 (hu) 2004-09-28
US7030138B2 (en) 2006-04-18
HUP0400384A3 (en) 2008-08-28
PL363961A1 (en) 2004-11-29
CA2442904A1 (en) 2002-10-17
AU2002246336B2 (en) 2005-05-19
CZ20032728A3 (cs) 2004-02-18
EP1375482A4 (en) 2005-01-19
NO20034439D0 (no) 2003-10-03
CN1610666A (zh) 2005-04-27
WO2002081448A1 (fr) 2002-10-17
IL158076A0 (en) 2004-03-28
EP1375482A1 (en) 2004-01-02
ZA200307646B (en) 2004-07-13
BR0208678A (pt) 2004-03-30
RU2003129502A (ru) 2005-04-10
RU2256652C1 (ru) 2005-07-20
KR20030087056A (ko) 2003-11-12
NZ528517A (en) 2004-08-27
CO5550436A2 (es) 2005-08-31
MXPA03009097A (es) 2004-02-12

Similar Documents

Publication Publication Date Title
NO20034439D0 (no) Benzamidinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
DK1419152T3 (da) HIV-hæmmende pyrimidin-derivater
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
DE60130463D1 (de) Pyrimidin-derivate
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE335486T1 (de) Hydrazono-malonitrile
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
NO20014597D0 (no) Fremgangsmåte
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
ATE330603T1 (de) Benzothiazolderivaten
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE60202381D1 (de) Paroxetin-n-formyl-derivate
ATA13992002A (de) Schlackengranulierungsanlage
DE60229395D1 (de) Altung
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
ATA2892002A (de) Beschlag
ATE345337T1 (de) Delta1 -pyrroline

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application